News - Page 207 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article Algernon Pharmaceuticals to Conduct Phase 1 DMT Stroke Program Study with Hammersmith Medicines Research (UK)

Algernon Pharmaceuticals to Conduct Phase 1 DMT Stroke Program Study with Hammersmith Medicines Research (UK)

Post published:March 1, 2021
Post category:Press Release

Read more about the article Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain

Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain

Post published:March 1, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: Field Trip Raising $83m; NYU Langone Launches Psychedelic Medicine Center; the Many Applications of DMT

Psychedelic Bulletin: Field Trip Raising $83m; NYU Langone Launches Psychedelic Medicine Center; the Many Applications of DMT

Post published:February 26, 2021
Post category:Psychedelic Bulletin

Read more about the article MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company

MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company

Post published:February 26, 2021
Post category:Press Release

Read more about the article Field Trip Health Announces Upsize to Previously Announced Bought Deal Public Offering

Field Trip Health Announces Upsize to Previously Announced Bought Deal Public Offering

Post published:February 26, 2021
Post category:Press Release

Read more about the article Field Trip Health Announces $50 Million Bought Deal Offering of Common Shares

Field Trip Health Announces $50 Million Bought Deal Offering of Common Shares

Post published:February 25, 2021
Post category:Press Release

Read more about the article Psilera Bioscience Obtains DEA Approval to Conduct Cutting Edge Psychedelics Research

Psilera Bioscience Obtains DEA Approval to Conduct Cutting Edge Psychedelics Research

Post published:February 25, 2021
Post category:Press Release

Read more about the article PsyBio Therapeutics Corp. Begins Trading on the TSX Venture Exchange

PsyBio Therapeutics Corp. Begins Trading on the TSX Venture Exchange

Post published:February 25, 2021
Post category:Press Release

Read more about the article Red Light Holland iMicrodose Pack Receives Authorization for the First Legal Import and Sale of Psilocybin Truffles to Brazil

Red Light Holland iMicrodose Pack Receives Authorization for the First Legal Import and Sale of Psilocybin Truffles to Brazil

Post published:February 25, 2021
Post category:Press Release

Read more about the article Yukoterre Announces Conditional Approval of Reverse Takeover Transaction With Silo Wellness

Yukoterre Announces Conditional Approval of Reverse Takeover Transaction With Silo Wellness

Post published:February 25, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.